Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 347

1.

Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study.

González GM, Treviño-Rangel Rde J, Palma-Nicolás JP, Martínez C, González JG, Ayala J, Caballero A, Morfín-Otero R, Rodríguez-Noriega E, Velarde F, Ascencio EP, Tinoco JC, Vázquez JA, Cano MA, León-Sicairos N, González R, Rincón J, Elías MA, Bonifaz A.

J Antimicrob Chemother. 2013 Dec;68(12):2847-51. doi: 10.1093/jac/dkt283. Epub 2013 Jul 18.

PMID:
23869052
2.

Epidemiology and antifungal susceptibility of bloodstream fungal isolates in pediatric patients: a Spanish multicenter prospective survey.

Pemán J, Cantón E, Linares-Sicilia MJ, Roselló EM, Borrell N, Ruiz-Pérez-de-Pipaon MT, Guinea J, García J, Porras A, García-Tapia AM, Pérez-Del-Molino L, Suárez A, Alcoba J, García-García I.

J Clin Microbiol. 2011 Dec;49(12):4158-63. doi: 10.1128/JCM.05474-11. Epub 2011 Oct 19.

3.

Candida and candidaemia. Susceptibility and epidemiology.

Arendrup MC.

Dan Med J. 2013 Nov;60(11):B4698. Review.

PMID:
24192246
4.

Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.

Pemán J, Cantón E, Quindós G, Eraso E, Alcoba J, Guinea J, Merino P, Ruiz-Pérez-de-Pipaon MT, Pérez-del-Molino L, Linares-Sicilia MJ, Marco F, García J, Roselló EM, Gómez-G-de-la-Pedrosa E, Borrell N, Porras A, Yagüe G; FUNGEMYCA Study Group..

J Antimicrob Chemother. 2012 May;67(5):1181-7. doi: 10.1093/jac/dks019. Epub 2012 Feb 20.

PMID:
22351683
5.

Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.

Xiao M, Fan X, Chen SC, Wang H, Sun ZY, Liao K, Chen SL, Yan Y, Kang M, Hu ZD, Chu YZ, Hu TS, Ni YX, Zou GL, Kong F, Xu YC.

J Antimicrob Chemother. 2015 Mar;70(3):802-10. doi: 10.1093/jac/dku460. Epub 2014 Dec 3.

PMID:
25473027
6.

Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.

Cantón E, Pemán J, Quindós G, Eraso E, Miranda-Zapico I, Álvarez M, Merino P, Campos-Herrero I, Marco F, de la Pedrosa EG, Yagüe G, Guna R, Rubio C, Miranda C, Pazos C, Velasco D; FUNGEMYCA Study Group..

Antimicrob Agents Chemother. 2011 Dec;55(12):5590-6. doi: 10.1128/AAC.00466-11. Epub 2011 Sep 19.

7.

Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.

Miranda-Zapico I, Eraso E, Hernández-Almaraz JL, López-Soria LM, Carrillo-Muñoz AJ, Hernández-Molina JM, Quindós G.

J Antimicrob Chemother. 2011 Oct;66(10):2315-22. doi: 10.1093/jac/dkr298. Epub 2011 Jul 26.

PMID:
21795259
8.

Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.

Borg-von Zepelin M, Kunz L, Rüchel R, Reichard U, Weig M, Gross U.

J Antimicrob Chemother. 2007 Aug;60(2):424-8. Epub 2007 Jun 11.

PMID:
17562683
9.

Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.

Martí-Carrizosa M, Sánchez-Reus F, March F, Coll P.

Scand J Infect Dis. 2014 Jun;46(6):454-61. doi: 10.3109/00365548.2014.900190. Epub 2014 Apr 24.

PMID:
24762093
10.

Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009).

Pfaller MA, Castanheira M, Messer SA, Moet GJ, Jones RN.

Diagn Microbiol Infect Dis. 2010 Nov;68(3):278-83. doi: 10.1016/j.diagmicrobio.2010.06.015. Epub 2010 Sep 16.

PMID:
20846808
11.
12.

Ten-year study of species distribution and antifungal susceptibilities of Candida bloodstream isolates at a Brazilian tertiary hospital.

Bonfietti LX, Szeszs MW, Chang MR, Martins MA, Pukinskas SR, Nunes MO, Pereira GH, Paniago AM, Purisco SU, Melhem MS.

Mycopathologia. 2012 Dec;174(5-6):389-96. doi: 10.1007/s11046-012-9566-3. Epub 2012 Jul 21.

PMID:
22821345
13.

Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.

Taj-Aldeen SJ, Kolecka A, Boesten R, Alolaqi A, Almaslamani M, Chandra P, Meis JF, Boekhout T.

Infection. 2014 Apr;42(2):393-404. doi: 10.1007/s15010-013-0570-4. Epub 2013 Dec 19.

PMID:
24352810
14.

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.

Arendrup MC, Dzajic E, Jensen RH, Johansen HK, Kjaeldgaard P, Knudsen JD, Kristensen L, Leitz C, Lemming LE, Nielsen L, Olesen B, Rosenvinge FS, Røder BL, Schønheyder HC.

Clin Microbiol Infect. 2013 Aug;19(8):E343-53. doi: 10.1111/1469-0691.12212. Epub 2013 Apr 22. Erratum in: Clin Microbiol Infect. 2013 Aug;19(8):E376.

15.

Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study.

Mokaddas EM, Al-Sweih NA, Khan ZU.

J Med Microbiol. 2007 Feb;56(Pt 2):255-9.

PMID:
17244809
16.

Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.

Blanco-Blanco MT, Gómez-García AC, Hurtado C, Galán-Ladero MA, Lozano Mdel C, García-Tapias A, Blanco MT.

Rev Iberoam Micol. 2014 Apr-Jun;31(2):145-8. doi: 10.1016/j.riam.2013.04.001. Epub 2013 May 13.

PMID:
23680638
17.

Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.

Bedini A, Venturelli C, Mussini C, Guaraldi G, Codeluppi M, Borghi V, Rumpianesi F, Barchiesi F, Esposito R.

Clin Microbiol Infect. 2006 Jan;12(1):75-80.

18.

Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.

Wisplinghoff H, Ebbers J, Geurtz L, Stefanik D, Major Y, Edmond MB, Wenzel RP, Seifert H.

Int J Antimicrob Agents. 2014 Jan;43(1):78-81. doi: 10.1016/j.ijantimicag.2013.09.005. Epub 2013 Oct 12.

PMID:
24182454
19.

Multicenter surveillance of species distribution and antifungal susceptibilities of Candida bloodstream isolates in South Korea.

Jung SI, Shin JH, Song JH, Peck KR, Lee K, Kim MN, Chang HH, Moon CS; Korean Study Group for Candidemia..

Med Mycol. 2010 Jun;48(4):669-74. doi: 10.3109/13693780903410386.

PMID:
20392145
20.

National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.

Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S.

J Antimicrob Chemother. 2004 Feb;53(2):283-9. Epub 2003 Dec 19.

PMID:
14688039

Supplemental Content

Support Center